CONGRESSWOMAN ELISE STEFANIK
Through a series of lies, blunders and cover-ups, the communist government of China has intensified the spread of the novel coronavirus. Tragically, the United States and over 130 other countries are now dealing with the serious health and economic impacts of this global emergency.
As the world grapples with the staggering impacts of COVID-19, which likely first infected humans in a live wildlife market in Wuhan, China, we are reminded of the deadly consequences of the global trade in wildlife. Live wildlife markets are ripe environments for the transmission of zoonotic disease, or diseases that originate in animals, to humans.
COVID-19 – the respiratory disease caused by the coronavirus – originated in Wuhan, China, and the first cases were reported Dec. 8, 2019. The virus spread like wildfire while the CCP not only turned a blind eye, but actively attempted to hide the disease from its own people and from the world.
The health of the world needs and benefits from the expertise of Taiwan’s healthcare researchers. The US’ expectation is that China looks beyond its pride and works together with Taiwan and the rest of the world before all continents become infected by this new Chinese plague.
However, while we still have a long path forward in the fight against coronavirus, it’s worth evaluating how we got from Wuhan to today. There are a few things we can praise about China’s handling of this virus, including strict quarantines of huge populations and limits on domestic and international travel. China should also be recognized as eventually cooperating with some of the international community in allowing teams of experts from the WHO to work directly with scientists in the mainland.
Affirming that all Chinese companies, private and state-owned, are under the effective control of the Chinese Communist Party.
Expressing the sense of the House of Representatives that the United States should withhold the contribution of Federal funds to the World Health Organization until Director-General Tedros Ghebreyesus resigns and an international commission to investigate the World Health Organization is established.
This bill prohibits extending the Measures for the Further Reduction and Limitation of Strategic Offensive Arms (New START treaty) or any successor agreement unless the agreement (1) includes and is signed by China, and (2) covers all Russian strategic and non-strategic nuclear forces.
This bill limits the investments of the International Stock Index Investment Fund (I Fund) under the Thrift Savings Plan. Specifically, it prohibits the I Fund from investing in any entity based in a peer or near-peer competitor nation, including China or Russia.
To prohibit United States persons from dealing in certain information and communications technology or services from foreign adversaries and to require the approval of Congress to terminate certain export controls in effect with respect to Huawei Technologies Co. Ltd., and for other purposes.
To prohibit the sharing of United States intelligence with countries that permit operation of Huawei fifth generation telecommunications technology within their borders.
To require the Committee on Foreign Investment in the United States to consider whether a foreign person that is a party to a transaction undergoing review by the Committee is connected to a foreign country that has installed information and communications technology designed, developed, manufactured, or supplied by persons owned or controlled by, or subject to the jurisdiction or direction of, a foreign adversary, and for other purposes.
To direct the President to develop a strategy to protect the space assets of the United States, and for other purposes.
To permit visiting dignitaries and service members from Taiwan to display the flag of the Republic of China.
Specifically, the bill will: (1) Track active pharmaceutical ingredients through an FDA registry. (2) Prohibit pharmaceutical purchases from China or products with active pharmaceutical ingredients created in China*. (3) Create transparency in the supply chain by instituting a country of origin label of all imported drugs. (4) Provide economic incentives for manufacturing drugs and medical equipment in the United States.
To authorize the imposition of sanctions with respect to the deliberate concealment or distortion of information about public health emergencies of international concern, and for other purposes.
To impose sanctions with respect to foreign telecommunications companies engaged in economic or industrial espionage against United States persons, and for other purposes.
Requires the Treasury Department to advocate for China’s graduation from World Bank lending and holds Treasury accountable for achieving this objective.
Requires the Treasury Department to 1) support IFI financing of 5G technologies only if such technologies provide appropriate security; 2) encourage IFI assistance for infrastructure and policy reforms that facilitate secure 5G; and 3) work with other IFI member countries to strengthen international support for secure 5G.
Requires the Treasury Department to strengthen international negotiations to seek greater Chinese compliance with OECD export subsidy principles.
Requires the Treasury Department to seek equal treatment of Taiwanese nationals seeking employment at each of the international financial institutions.
Prohibits the authorization of shareholding increases for China at the International Monetary Fund unless China 1) upholds the principles of the Fund’s Articles of Agreement; 2) has not engaged in currency manipulation for 12 months; 3) has a “freely usable” currency; and 4) commits to the rules and principles of the Paris Club with regard to debt transparency and restructuring.
Amends the Defense Production Act (DPA) to use its authority to ensure the availability of medical articles through supply chain diversification.
Expressing the sense of the House of Representatives that the People’s Republic of China should be held accountable for its handling of COVID-19.
This concurrent resolution establishes the Joint Select Committee on the Events and Activities Surrounding China’s Handling of the 2019 Novel Coronavirus to investigate and report to Congress and the executive branch, including recommendations on the origins and causes of the coronavirus (i.e., the virus that causes COVID-19); certain coronavirus-related policies, decisions, and activities by the government of China; accountability for policies, decisions, and activities related to influencing the World Health Organization’s response to the coronavirus outbreak; vulnerabilities in the U.S. domestic and global supply chain to combat a global pandemic due to reliance on Chinese manufacturing; information related to lessons learned from China’s handling of the coronavirus; and actions the federal government should take in response to China’s handling of the coronavirus.
Commending the people of Taiwan on holding free and fair democratic presidential and legislative elections, and congratulating Madame Tsai Ing-wen on her re-election to the presidency of Taiwan.
Recognizing the significance of the genuine autonomy of Tibet and the Tibetan people and the work His Holiness the 14th Dalai Lama has done to promote global peace, harmony, and understanding.